Since 2018: SAF-HOLLAND SE Chief Internal Auditor Chief Internal Auditor in Frankfurt listed company (S-DAX) with c 6,000 employees generating EUR 2.1 billion revenue in 2023. Completion of over 50 internal audits (management, strategy incl. post investment reviews, operations, finance/IFRS accounting and compliance), ad-hoc reviews and consulting assignments. April to September 2020: Head of Global Cash is King Project contributing to halve past due Receivables in 6 months. June to August 2020: supported the CEO running the CFO Office in parallel, bridging an interim period. SAF-HOLLAND manufactures and supplies chassis-related systems and components for trailers and semi-trailers as well as for trucks and buses worldwide.
2014 - 2018: Villeroy & Boch AG Chief Internal Auditor Chief Internal Auditor in Frankfurt listed company with 8,000 employees generating €837 million revenue (2017) in 125 countries around the world with 14 production facilities in Europe, Mexico and Thailand. Completion of over 100 internal audits (management, strategy, operations, finance/IFRS accounting and compliance), ad-hoc reviews, and consulting assignments in 25 countries. Project leader M&A.
2013 - 2014 (winter term): Université catholique de Louvain, Mons, Belgium
Professor Audit & Control, Tenure track
2001 – 2013: Actavis (Alpharma until 2005)
VP Internal Audit, VP Finance, CFO Europe and Asia; VP Finance, CFO International 2007-2013: Chief Internal Auditor of the Actavis Group (€2 billion annual revenue - 40 countries - 10,000 employees) until 2013 when the company was sold to Watson @ $5.5 billion (then to Allergan, most lately to Teva). Established Internal Audit as highly valued business partner based on efficient and collaborative engagement with senior corporate and business unit leadership. Managing Director (Geschäftsführer) of Actavis Deutschland GmbH & Co. KG.
2006-2007: Regional CFO Europe and Asia of the Actavis Group, provided financial leadership, control and commercial support to all functional areas of non-US business units worth €1 billion in annual revenue. Conducted due diligence of over 30 mergers and acquisitions, as well as integration of 7 companies in 6 European and Asian countries. Streamlined internal transactions and reduced effective tax rates by establishing Principal Trading Company. Managing Director (Geschäftsführer) of Actavis Deutschland GmbH & Co. KG.
2001-2005: Divisional CFO of NYSE-listed Company @Alpharma [Formerly: ALO], served as head of the international finance team of 100 supporting International Generics and Active Pharmaceutical Ingredients business units across several multinational locations. Managed over $500 million in annual revenue.
1997 – 2001: Schlumberger, Resource Management Services (RMS) Controller RMS Germany, Managing Director SEWA GmbH Controller RMS Water & Heat Germany
1994 – 1997: ABB Calor Emag Finance Manager Deputy Purchasing Manager Supply Chain / Purchasing Trainee
1993: apetito Executive Assistant to the CEO |